Skip to main content
. 2009 Jun 1;100(9):1735–1739. doi: 10.1111/j.1349-7006.2009.01233.x

Table 4.

Detection rates of primary and metastatic breast cancer (n = 147) using a combination of three tumor markers

Combination of tumor markers No. of cases (%)
1. CA15‐3/CEA/NCCST‐439 positive 44 (29.9%)
2. Midkine/CA15‐3/CEA positive 66 (44.9%)
3. Midkine/CA15‐3/NCCST‐439 positive 61 (41.5%)
4. Midkine/CEA/NCCST‐439 positive 66 (44.9%)

1 vs 2, P < 0.0001; 1 vs 3, P = 0.0031; 1 vs 4, P < 0.0001 (McNeman test).